Back to Top Skip to main content Skip to sub-navigation

Vaccine Recommendations by AOR

For general policy guidance on every vaccine, please see the Joint Regulation on Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases (AR 40-562, BUMEDINST 6230.15B, AFI 48-110_IP, CG COMDTINST M6230.4G).

Travel Alerts

Travel notices are designed to inform travelers and clinicians about current health issues related to specific destinations. These issues may arise from disease outbreaks, special events or gatherings, natural disasters, or other conditions that may affect travelers’ health. >>View current and ongoing travel alerts

Click here for a high-resolution copy of the map below.

AOR Map

USAFRICOM

Vaccine  Administration Required for AFRICOM
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL 
Required.
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml

Required if you are residing in / traveling to a designated NH vaccine country by the WHO for 14 or more days from October through March.

 Influenza, Southern Hemisphere (SH)
  • Schedule: 1 dose annually
  • Route: Intramuscular
  • Dose: IM 0.5ml

Required if you are residing in / traveling to a designated SH vaccine country by the WHO for 14 or more days from April through September.

 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Meningococcal
  • Schedule: Every 5 yrs.
  • Route: Intramuscular 
  • Dose: 0.5ml
Required.
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
Required. See additional guidance for travel to and from USAFRICOM countries affected by polio. See also Interim CDC Guidance for Travel to high risk countries.
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
Required for personnel at high risk for exposure IAW Service-Specific guidelines.
 Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml
Required.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
Required.
 Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Yellow Fever
  • Schedule: 1 lifetime dose. Must be administered 10 days prior to travel.
  • Route: Subcutaneous
  • Dose: 0.5ml
Required except for Comoros, Morocco and Tunisia. All YF vaccinations must be documented on a CDC 731. See exception for Ascension Island.

Back to top of page

 

USCENTCOM

Vaccine  Administration Required for CENTCOM
 Anthrax
  • Schedule: 0,4w,6,12,18m + annual booster
  • Route: Intramuscular
  • Dose: 0.5ml
Required for 15 or more days in theater.
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL 
Required.
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml
Required.
 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required. Documentation must include one of the following: Born before 1957, effective immunity by titer, or administration of two lifetime doses.
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
For individuals traveling for > 4 weeks, vaccination required to be administered within 12 months of DEPARTURE FROM Afghanistan and Pakistan.
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
Required for personnel at high risk for exposure IAW Service-Specific guidelines.
 Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml 
Required.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
Required.
  Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required. Documentation must include one of the following: Born before 1980, history of disease, sufficient varicella titer, or administration of vaccine.

Back to top of page

USEUCOM

Vaccine  Administration Required for EUCOM
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL  
Required.
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml
Required.
 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Meningococcal
  • Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs.
  • Route: Intramuscular 
  • Dose: 0.5ml
Specific countries only - See NCMI recommendations.
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml 
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
Required. 
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
Required for personnel at high risk for exposure IAW Service-Specific guidelines.
 Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml 
Required.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)

Required for countries with intermediate or high risk per NCMI, to include: Albania, Georgia, Israel, Kosovo, Macedonia, Moldova, Montenegro, Romania, Russia, Serbia, Turkey and Ukraine.

 Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Yellow Fever
  • Schedule: 1 lifetime dose. Must be administered 10 days prior to travel.
  • Route: Subcutaneous
  • Dose: 0.5ml
Specific countries only - See YF vaccine transiting requirements.

Back to top of page

 

USINDOPACOM

Vaccine  Administration Required for INDOPACOM 
 Anthrax
  • Schedule: 0,4w,6,12,18m + annual booster
  • Route: Intramuscular
  • Dose: 0.5ml
Required for travel of 15 days or longer to Korea, to include forward deployed Naval forces. Required for III MEF. All others per DoD policy.
 Cholera
  • Schedule: 1 dose
  • Route: Oral
  • Dose: 100mL oral suspension
Not routinely recommended but may be indicated for deployment to high risk situations. Consult with local Prev Med/Public Health for additional guidance.
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL  
Required.
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml

Required if you are residing in / traveling to a designated NH vaccine country by the WHO for 14 or more days from October through March.

 Influenza, Southern Hemisphere (SH)
  • Schedule: 1 dose annually
  • Route: Intramuscular
  • Dose: IM 0.5ml

Required if you are residing in / traveling to a designated SH vaccine country by the WHO (including Diego Garcia) for 14 or more days from April through September.

 Japanese encephalitis
  • Schedule: 0,28 d (2 dose). One-time booster dose if >11 months after series complete and still in endemic area.
  • Route: Intramuscular
  • Dose: 0.5ml

Required for all Air Force, Army Special Operations Forces (ARSOF), Navy and Marine Corps personnel stationed, deployed, or TAD (ashore or afloat) to Japan or Korea for 30 or more consecutive days. Recommended for all others. Every effort should be made to complete the vaccine series prior to arrival.

 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Meningococcal
  • Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs.
  • Route:  Intramuscular
  • Dose: 0.5mL
Specific countries only - See NCMI recommendations.
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml 
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
Required. In the setting of a polio outbreak, comply with CDC or WHO recommendations and if in-country deployment is > 4 weeks, vaccination is required prior to arriving in country. 
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
Required for personnel at high risk for exposure IAW Service-Specific guidelines
Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml 
Required.
 Tick-Borne Encephalitis
  • Schedule: 0, 14d-3m, 5-12m (3 dose) + one-time booster dose 3 years after primary series, if continued exposure expected.
  • Route: Intramuscular
  • Dose: 0.5mL
May be indicated when traveling to forested areas where the disease is endemic, and considered if personal protective measures to prevent insect bites are difficult or suspect.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
Required for Korea, III MEF and Operational Forces. All others per DoD policy.
 Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
Yellow Fever
  • Schedule: 1 lifetime dose. Must be administered 10 days prior to travel.
  • Route: Subcutaneous
  • Dose: 0.5ml

Required only for entry into some USINDOPACOM countries (per CDC Yellow Book) if traveling from, or transiting through, endemic areas (Africa & South America). CDC 731 Stamp required.

Back to top of page

USNORTHCOM

Vaccine  Administration Academies - ROTC  Coast Guard  Initial Entry Training  Service members in USA 
 Anthrax
  • Schedule: 0,4w,6,12,18m + annual booster
  • Route: Intramuscular
  • Dose: 0.5ml
 N/A Per USCG Policy. N/A Per DoD Policy. 
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required. Required.
Required.
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL  
Required.
Required.
Required.
Per DoD Policy.
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml
Required.
Required.
Required.
Required.
 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
Required.
Required.
Required.
 Meningococcal
  • Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs.
  • Route: Intramuscular 
  • Dose: 0.5ml
Required Academies Only. N/A Required.  N/A
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml 
N/A
Required for asplenic and other high risk health conditions per ACIP.
San Diego: 1 dose.
Parris Island: 1 dose.
Cape May: 1 dose.
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
Required.
Required.
Required.
Required.
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
N/A
Per USCG Policy. N/A
Required for personnel at high risk for exposure IAW Service-Specific guidelines
 Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml 
Required.
Required.
Required.
Required.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
N/A
Per USCG Policy.
N/A
N/A
 Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
Required.
Required.
Required.

Back to top of page

USSOUTHCOM

Vaccine  Administration Required for SOUTHCOM (includes Haiti)
 COVID-19
  • Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines. 
  • Route: Intramuscular
  • Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
 Hepatitis A
  • Schedule: 0, 6m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
Required.
 Hepatitis B
  • Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
  • Route: Intramuscular
  • Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL  
Required. 
 Influenza, Northern Hemisphere (NH)
  • Schedule: 1 dose annually
  • Route: Intramuscular, Intranasal
  • Dose: IM 0.5ml; Intranasal 0.2ml

Required if you are residing in / traveling to a designated NH vaccine country by the WHO for 14 or more days from October through March.

 Influenza, Southern Hemisphere (SH)
  • Schedule: 1 dose annually
  • Route: Intramuscular
  • Dose: IM 0.5ml

Required if you are residing in / traveling to a designated SH vaccine country by the WHO for 14 or more days from April through September. Exception: Cuba not required.

 M-M-R
  • Schedule: 2 lifetime doses or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Pneumococcal
  • Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
  • Route: PPSV23: SC or IM; PCV15 & PCV20: IM
  • Dose: 0.5ml 
Required for high risk health conditions per ACIP.
 Polio
  • Schedule: 1 dose as adult
  • Route: Subcutaneous or Intramuscular
  • Dose: 0.5ml
Required.
 Rabies
  • Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
  • Route: Intramuscular
  • Dose: 1ml
Required for personnel at high risk for exposure IAW Service-Specific guidelines.
 Tdap or Td
  • Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
  • Route: Intramuscular
  • Dose: 0.5ml 
Required.
 Typhoid
  • Schedule: Injectable: every 2 yr; Oral: every 5 yr
  • Route: Intramuscular or Oral
  • Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
Required.
 Varicella (chickenpox)
  • Schedule: 0, 4-8w (2 dose) or + serologic testing
  • Route: Subcutaneous
  • Dose: 0.5ml
Required.
 Yellow Fever
  • Schedule: 1 lifetime dose. Must be administered 10 days prior to travel.
  • Route: Subcutaneous
  • Dose: 0.5ml

Required for countries where the disease is endemic, per the CDC.

Required if traveling from an endemic area to those countries with transiting requirements (per WHO) and per USSOUTHCOM memo dated November 28, 2018.

Back to top of page

Regional Vaccine Recommendations provided for informational reference purposes only.
Always vaccinate according to package inserts and DoD/Service guidelines.

You also may be interested in...

U.S. Army Special Operations Command Supplement 1 to Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases

Policy

Immunization Recommendations for Disaster Response Operations

Fact Sheet
8/30/2017

This information paper provides immunization recommendations and resources for Department of Defense (DOD) personnel supporting disaster response operations, both in CONUS and OCONUS.

Recommended Content:

Vaccine-Preventable Diseases | Vaccine Recommendations by AOR | Humanitarian Assistance and Disaster Relief | Vaccine Schedules | Hepatitis A | Hepatitis B | Influenza, Northern Hemisphere | Tetanus-Diphtheria-Pertussis | Rabies

BUMED Memo 6000: Japanese Encephalitis Vaccine

Policy

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

Report
6/9/2017

A review of surveillance and immunization program data in the 24 countries with JE virus transmission risk found that in 2016, 22 countries conducted at least some surveillance for JE, and 12 had implemented a JE immunization program.

Recommended Content:

Japanese Encephalitis | Vaccine Recommendations by AOR

AF-SG3-5 Memo - Clarification of Air Force Mumps Vaccination Guidance

Policy

COMPACFLT Guidance on the Japanese Encephalitis Vaccine for U.S. Navy Personnel and TRICARE beneficiaries in the Pacific Fleet Area of Responsibility

Policy

Guidance on the Japanese Encephalitis Vaccine for US Army Personnel in the Pacific Area of Responsibility (Expired 1 DEC 17)

Policy

Guidance on the Japanese Encephalitis Vaccine for US Army Personnel in the Pacific Area of Responsibility

Showing results 1 - 7 Page 1 of 1
Last Updated: September 09, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.